Lily says that it is acquiring psychedelic drug developer Tai Beckley. And Lily will pay $675 in cash or $2.8% billion upfront and another1 billion if certain developmental and regulatory milestones are met. And so a Tai Beckley, their lead drug is related to the psychedelic drug DMT.And the company's testing it for treatment resistant depression. And it's a nasal spray that's a little bit like um J&J's drug spado. So it's administered in a clinic and then patients are monitored for a couple hours and again ...